PARP inhibitors in the treatment of ovarian cancer: a narrative review.

Wang Y, Li X, Yang Y, Lv X, Wang K, Li H, Liu X, Jin K, Gao M

DOI: 10.21037/tcr-2026-1-0258
Published: 2026 Apr 30
Container: Translational cancer research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.21037/tcr-2026-1-0258,
  title = {PARP inhibitors in the treatment of ovarian cancer: a narrative review.},
  author = {Wang Y and Li X and Yang Y and Lv X and Wang K and Li H and Liu X and Jin K and Gao M},
  year = {2026},
  journal = {Translational cancer research},
  doi = {10.21037/tcr-2026-1-0258},
  url = {https://doi.org/10.21037/tcr-2026-1-0258}
}

RIS

TY  - JOUR
TI  - PARP inhibitors in the treatment of ovarian cancer: a narrative review.
AU  - Wang Y
AU  - Li X
AU  - Yang Y
AU  - Lv X
AU  - Wang K
AU  - Li H
AU  - Liu X
AU  - Jin K
AU  - Gao M
PY  - 2026
JO  - Translational cancer research
DO  - 10.21037/tcr-2026-1-0258
UR  - https://doi.org/10.21037/tcr-2026-1-0258
ER  -

APA

Y, W., X, L., Y, Y., X, L., K, W., H, L., X, L., K, J., & M, G. (2026). PARP inhibitors in the treatment of ovarian cancer: a narrative review.. Translational cancer research. https://doi.org/10.21037/tcr-2026-1-0258

Source records

pubmed · retrieved 2026-09-26T08:16:35.903Z